author_facet Li, Z.
Wu, J.
Zhao, Y.
Liu, R.
Li, K.
Zhou, Y.
Wu, R.
Yang, R.
Zhang, X.
Lian, S.
Hu, Q.
Li, X.
Gu, J.
Zhou, R.
Sun, J.
Li, C.
Xu, W.
Poon, M.‐C.
Xiao, J.
Li, Z.
Wu, J.
Zhao, Y.
Liu, R.
Li, K.
Zhou, Y.
Wu, R.
Yang, R.
Zhang, X.
Lian, S.
Hu, Q.
Li, X.
Gu, J.
Zhou, R.
Sun, J.
Li, C.
Xu, W.
Poon, M.‐C.
Xiao, J.
author Li, Z.
Wu, J.
Zhao, Y.
Liu, R.
Li, K.
Zhou, Y.
Wu, R.
Yang, R.
Zhang, X.
Lian, S.
Hu, Q.
Li, X.
Gu, J.
Zhou, R.
Sun, J.
Li, C.
Xu, W.
Poon, M.‐C.
Xiao, J.
spellingShingle Li, Z.
Wu, J.
Zhao, Y.
Liu, R.
Li, K.
Zhou, Y.
Wu, R.
Yang, R.
Zhang, X.
Lian, S.
Hu, Q.
Li, X.
Gu, J.
Zhou, R.
Sun, J.
Li, C.
Xu, W.
Poon, M.‐C.
Xiao, J.
Haemophilia
Influence of medical insurance schemes and charity assistance projects on regular prophylaxis treatment of the boys with severe haemophilia A in China
Genetics (clinical)
Hematology
General Medicine
author_sort li, z.
spelling Li, Z. Wu, J. Zhao, Y. Liu, R. Li, K. Zhou, Y. Wu, R. Yang, R. Zhang, X. Lian, S. Hu, Q. Li, X. Gu, J. Zhou, R. Sun, J. Li, C. Xu, W. Poon, M.‐C. Xiao, J. 1351-8216 1365-2516 Wiley Genetics (clinical) Hematology General Medicine http://dx.doi.org/10.1111/hae.13372 <jats:sec><jats:title>Objective</jats:title><jats:p>To explore the influence of medical insurance policy and charity assistance projects on the uptake and discontinuation of regular prophylaxis treatment in Chinese severe haemophilia A children.</jats:p></jats:sec><jats:sec><jats:title>Methodology</jats:title><jats:p>This retrospective study was conducted on children with severe haemophilia A, who received <jats:styled-content style="fixed-case">FVIII</jats:styled-content> prophylaxis treatment at 12 haemophilia centres in China from 1 November 2007 to 31 May 2013.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>The average duration of prophylaxis treatment received by haemophilia children significantly increased from 16.7 weeks in 2008 to 32.8 weeks in 2012 (<jats:italic>P </jats:italic>&lt;<jats:italic> </jats:italic>.001). The main reason for prophylaxis acceptance included dissatisfaction with previous “on‐demand” regimens, availability of improved local medical insurance policies and patient/family awareness of haemophilia. The main reason for subsequent discontinuation of prophylaxis was economic instability. The upper limit of insurance was up to <jats:styled-content style="fixed-case">RMB</jats:styled-content> 150 000/y (~<jats:styled-content style="fixed-case">USD</jats:styled-content>: 22 000/y) for 80.1% of the insured patients and would be sufficient to cover the continuous low‐dose prophylaxis regimen. However, for many patients the burden of out‐of‐pocket copayment cost represented a risk for poor adherence to regular prophylaxis. In about two third of the patients, the annual out‐of‐pocket copayment cost amounted to &gt;50% of their average annual disposable income. Many patients therefore required assistance from the charity assistance projects, but nonadherence remained prevalent.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Medical insurance policy and charity assistance projects helped haemophilia children to accept and continue prophylaxis regimens. It was the proportion of the out‐of‐pocket copayment cost rather than the upper limit of insurance reimbursement that restricted long‐term regular low‐dose prophylaxis in China.</jats:p></jats:sec> Influence of medical insurance schemes and charity assistance projects on regular prophylaxis treatment of the boys with severe haemophilia A in China Haemophilia
doi_str_mv 10.1111/hae.13372
facet_avail Online
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9oYWUuMTMzNzI
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9oYWUuMTMzNzI
institution DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
imprint Wiley, 2018
imprint_str_mv Wiley, 2018
issn 1351-8216
1365-2516
issn_str_mv 1351-8216
1365-2516
language English
mega_collection Wiley (CrossRef)
match_str li2018influenceofmedicalinsuranceschemesandcharityassistanceprojectsonregularprophylaxistreatmentoftheboyswithseverehaemophiliaainchina
publishDateSort 2018
publisher Wiley
recordtype ai
record_format ai
series Haemophilia
source_id 49
title Influence of medical insurance schemes and charity assistance projects on regular prophylaxis treatment of the boys with severe haemophilia A in China
title_unstemmed Influence of medical insurance schemes and charity assistance projects on regular prophylaxis treatment of the boys with severe haemophilia A in China
title_full Influence of medical insurance schemes and charity assistance projects on regular prophylaxis treatment of the boys with severe haemophilia A in China
title_fullStr Influence of medical insurance schemes and charity assistance projects on regular prophylaxis treatment of the boys with severe haemophilia A in China
title_full_unstemmed Influence of medical insurance schemes and charity assistance projects on regular prophylaxis treatment of the boys with severe haemophilia A in China
title_short Influence of medical insurance schemes and charity assistance projects on regular prophylaxis treatment of the boys with severe haemophilia A in China
title_sort influence of medical insurance schemes and charity assistance projects on regular prophylaxis treatment of the boys with severe haemophilia a in china
topic Genetics (clinical)
Hematology
General Medicine
url http://dx.doi.org/10.1111/hae.13372
publishDate 2018
physical 126-133
description <jats:sec><jats:title>Objective</jats:title><jats:p>To explore the influence of medical insurance policy and charity assistance projects on the uptake and discontinuation of regular prophylaxis treatment in Chinese severe haemophilia A children.</jats:p></jats:sec><jats:sec><jats:title>Methodology</jats:title><jats:p>This retrospective study was conducted on children with severe haemophilia A, who received <jats:styled-content style="fixed-case">FVIII</jats:styled-content> prophylaxis treatment at 12 haemophilia centres in China from 1 November 2007 to 31 May 2013.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>The average duration of prophylaxis treatment received by haemophilia children significantly increased from 16.7 weeks in 2008 to 32.8 weeks in 2012 (<jats:italic>P </jats:italic>&lt;<jats:italic> </jats:italic>.001). The main reason for prophylaxis acceptance included dissatisfaction with previous “on‐demand” regimens, availability of improved local medical insurance policies and patient/family awareness of haemophilia. The main reason for subsequent discontinuation of prophylaxis was economic instability. The upper limit of insurance was up to <jats:styled-content style="fixed-case">RMB</jats:styled-content> 150 000/y (~<jats:styled-content style="fixed-case">USD</jats:styled-content>: 22 000/y) for 80.1% of the insured patients and would be sufficient to cover the continuous low‐dose prophylaxis regimen. However, for many patients the burden of out‐of‐pocket copayment cost represented a risk for poor adherence to regular prophylaxis. In about two third of the patients, the annual out‐of‐pocket copayment cost amounted to &gt;50% of their average annual disposable income. Many patients therefore required assistance from the charity assistance projects, but nonadherence remained prevalent.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Medical insurance policy and charity assistance projects helped haemophilia children to accept and continue prophylaxis regimens. It was the proportion of the out‐of‐pocket copayment cost rather than the upper limit of insurance reimbursement that restricted long‐term regular low‐dose prophylaxis in China.</jats:p></jats:sec>
container_issue 1
container_start_page 126
container_title Haemophilia
container_volume 24
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792339191491723266
geogr_code not assigned
last_indexed 2024-03-01T15:44:11.909Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Influence+of+medical+insurance+schemes+and+charity+assistance+projects+on+regular+prophylaxis+treatment+of+the+boys+with+severe+haemophilia+A+in+China&rft.date=2018-01-01&genre=article&issn=1365-2516&volume=24&issue=1&spage=126&epage=133&pages=126-133&jtitle=Haemophilia&atitle=Influence+of+medical+insurance+schemes+and+charity+assistance+projects+on+regular+prophylaxis+treatment+of+the+boys+with+severe+haemophilia+A+in+China&aulast=Xiao&aufirst=J.&rft_id=info%3Adoi%2F10.1111%2Fhae.13372&rft.language%5B0%5D=eng
SOLR
_version_ 1792339191491723266
author Li, Z., Wu, J., Zhao, Y., Liu, R., Li, K., Zhou, Y., Wu, R., Yang, R., Zhang, X., Lian, S., Hu, Q., Li, X., Gu, J., Zhou, R., Sun, J., Li, C., Xu, W., Poon, M.‐C., Xiao, J.
author_facet Li, Z., Wu, J., Zhao, Y., Liu, R., Li, K., Zhou, Y., Wu, R., Yang, R., Zhang, X., Lian, S., Hu, Q., Li, X., Gu, J., Zhou, R., Sun, J., Li, C., Xu, W., Poon, M.‐C., Xiao, J., Li, Z., Wu, J., Zhao, Y., Liu, R., Li, K., Zhou, Y., Wu, R., Yang, R., Zhang, X., Lian, S., Hu, Q., Li, X., Gu, J., Zhou, R., Sun, J., Li, C., Xu, W., Poon, M.‐C., Xiao, J.
author_sort li, z.
container_issue 1
container_start_page 126
container_title Haemophilia
container_volume 24
description <jats:sec><jats:title>Objective</jats:title><jats:p>To explore the influence of medical insurance policy and charity assistance projects on the uptake and discontinuation of regular prophylaxis treatment in Chinese severe haemophilia A children.</jats:p></jats:sec><jats:sec><jats:title>Methodology</jats:title><jats:p>This retrospective study was conducted on children with severe haemophilia A, who received <jats:styled-content style="fixed-case">FVIII</jats:styled-content> prophylaxis treatment at 12 haemophilia centres in China from 1 November 2007 to 31 May 2013.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>The average duration of prophylaxis treatment received by haemophilia children significantly increased from 16.7 weeks in 2008 to 32.8 weeks in 2012 (<jats:italic>P </jats:italic>&lt;<jats:italic> </jats:italic>.001). The main reason for prophylaxis acceptance included dissatisfaction with previous “on‐demand” regimens, availability of improved local medical insurance policies and patient/family awareness of haemophilia. The main reason for subsequent discontinuation of prophylaxis was economic instability. The upper limit of insurance was up to <jats:styled-content style="fixed-case">RMB</jats:styled-content> 150 000/y (~<jats:styled-content style="fixed-case">USD</jats:styled-content>: 22 000/y) for 80.1% of the insured patients and would be sufficient to cover the continuous low‐dose prophylaxis regimen. However, for many patients the burden of out‐of‐pocket copayment cost represented a risk for poor adherence to regular prophylaxis. In about two third of the patients, the annual out‐of‐pocket copayment cost amounted to &gt;50% of their average annual disposable income. Many patients therefore required assistance from the charity assistance projects, but nonadherence remained prevalent.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Medical insurance policy and charity assistance projects helped haemophilia children to accept and continue prophylaxis regimens. It was the proportion of the out‐of‐pocket copayment cost rather than the upper limit of insurance reimbursement that restricted long‐term regular low‐dose prophylaxis in China.</jats:p></jats:sec>
doi_str_mv 10.1111/hae.13372
facet_avail Online
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9oYWUuMTMzNzI
imprint Wiley, 2018
imprint_str_mv Wiley, 2018
institution DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1
issn 1351-8216, 1365-2516
issn_str_mv 1351-8216, 1365-2516
language English
last_indexed 2024-03-01T15:44:11.909Z
match_str li2018influenceofmedicalinsuranceschemesandcharityassistanceprojectsonregularprophylaxistreatmentoftheboyswithseverehaemophiliaainchina
mega_collection Wiley (CrossRef)
physical 126-133
publishDate 2018
publishDateSort 2018
publisher Wiley
record_format ai
recordtype ai
series Haemophilia
source_id 49
spelling Li, Z. Wu, J. Zhao, Y. Liu, R. Li, K. Zhou, Y. Wu, R. Yang, R. Zhang, X. Lian, S. Hu, Q. Li, X. Gu, J. Zhou, R. Sun, J. Li, C. Xu, W. Poon, M.‐C. Xiao, J. 1351-8216 1365-2516 Wiley Genetics (clinical) Hematology General Medicine http://dx.doi.org/10.1111/hae.13372 <jats:sec><jats:title>Objective</jats:title><jats:p>To explore the influence of medical insurance policy and charity assistance projects on the uptake and discontinuation of regular prophylaxis treatment in Chinese severe haemophilia A children.</jats:p></jats:sec><jats:sec><jats:title>Methodology</jats:title><jats:p>This retrospective study was conducted on children with severe haemophilia A, who received <jats:styled-content style="fixed-case">FVIII</jats:styled-content> prophylaxis treatment at 12 haemophilia centres in China from 1 November 2007 to 31 May 2013.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>The average duration of prophylaxis treatment received by haemophilia children significantly increased from 16.7 weeks in 2008 to 32.8 weeks in 2012 (<jats:italic>P </jats:italic>&lt;<jats:italic> </jats:italic>.001). The main reason for prophylaxis acceptance included dissatisfaction with previous “on‐demand” regimens, availability of improved local medical insurance policies and patient/family awareness of haemophilia. The main reason for subsequent discontinuation of prophylaxis was economic instability. The upper limit of insurance was up to <jats:styled-content style="fixed-case">RMB</jats:styled-content> 150 000/y (~<jats:styled-content style="fixed-case">USD</jats:styled-content>: 22 000/y) for 80.1% of the insured patients and would be sufficient to cover the continuous low‐dose prophylaxis regimen. However, for many patients the burden of out‐of‐pocket copayment cost represented a risk for poor adherence to regular prophylaxis. In about two third of the patients, the annual out‐of‐pocket copayment cost amounted to &gt;50% of their average annual disposable income. Many patients therefore required assistance from the charity assistance projects, but nonadherence remained prevalent.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Medical insurance policy and charity assistance projects helped haemophilia children to accept and continue prophylaxis regimens. It was the proportion of the out‐of‐pocket copayment cost rather than the upper limit of insurance reimbursement that restricted long‐term regular low‐dose prophylaxis in China.</jats:p></jats:sec> Influence of medical insurance schemes and charity assistance projects on regular prophylaxis treatment of the boys with severe haemophilia A in China Haemophilia
spellingShingle Li, Z., Wu, J., Zhao, Y., Liu, R., Li, K., Zhou, Y., Wu, R., Yang, R., Zhang, X., Lian, S., Hu, Q., Li, X., Gu, J., Zhou, R., Sun, J., Li, C., Xu, W., Poon, M.‐C., Xiao, J., Haemophilia, Influence of medical insurance schemes and charity assistance projects on regular prophylaxis treatment of the boys with severe haemophilia A in China, Genetics (clinical), Hematology, General Medicine
title Influence of medical insurance schemes and charity assistance projects on regular prophylaxis treatment of the boys with severe haemophilia A in China
title_full Influence of medical insurance schemes and charity assistance projects on regular prophylaxis treatment of the boys with severe haemophilia A in China
title_fullStr Influence of medical insurance schemes and charity assistance projects on regular prophylaxis treatment of the boys with severe haemophilia A in China
title_full_unstemmed Influence of medical insurance schemes and charity assistance projects on regular prophylaxis treatment of the boys with severe haemophilia A in China
title_short Influence of medical insurance schemes and charity assistance projects on regular prophylaxis treatment of the boys with severe haemophilia A in China
title_sort influence of medical insurance schemes and charity assistance projects on regular prophylaxis treatment of the boys with severe haemophilia a in china
title_unstemmed Influence of medical insurance schemes and charity assistance projects on regular prophylaxis treatment of the boys with severe haemophilia A in China
topic Genetics (clinical), Hematology, General Medicine
url http://dx.doi.org/10.1111/hae.13372